Company profile for Prometheus Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Prometheus Biosciences is a biopharmaceutical company focused on the discovery and development of a broad portfolio of precision therapeutics and companion diagnostics for gastrointestinal (GI) diseases and disorders. Prometheus has an extensive clinical biobank with paired longitudinal medical records that has enabled identification of novel targets for treatment of patients with biomarker-defined subclinical GI phenotypes.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
9410 Carroll Park Dr. San Diego, CA 92121
Telephone
Telephone
(858) 200-7888
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.merck.com/news/merck-signs-agreement-with-dr-falk-pharma-gmbh-for-certain-development-and-commercialization-rights-to-mk-8690-pra-052-an-investigational-anti-cd30-ligand-monoclonal-antibody/

PRESS RELEASE
04 Nov 2025
Prometheus team returns with brand-new biotech and $400M
Prometheus team returns with brand-new biotech and $400M

21 Mar 2024

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/investors-fund-prometheus-teams-unfinished-business-400m-new-inflammatory-biotech-mirador

Annalee Armstrong FIERCE BIOTECH
21 Mar 2024
Merck closes $10.8B deal with Prometheus
Merck closes $10.8B deal with Prometheus

17 Jun 2023

// Jaimy Lee ENDPTS

https://endpts.com/merck-close-10-8b-deal-with-prometheus/

Jaimy Lee ENDPTS
17 Jun 2023

https://www.businesswire.com/news/home/20230522005656/en/PROMETHEUS-BIOSCIENCES-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Prometheus-Biosciences-Inc.---RXDX

BUSINESSWIRE
22 May 2023

https://www.globenewswire.com/news-release/2023/05/09/2664888/0/en/Prometheus-Biosciences-Reports-First-Quarter-2023-Financial-Results-and-Highlights-Recent-Corporate-Progress.html

GLOBENEWSWIRE
09 May 2023
Merck battled 2 other Big Pharmas in pursuit of Prometheus
Merck battled 2 other Big Pharmas in pursuit of Prometheus

02 May 2023

// Annalee Armstrong FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/merck-battled-2-other-big-pharmas-pursuit-11b-prometheus-deal

Annalee Armstrong FIERCE BIOTECH
02 May 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty